| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.066 | 0.04 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.05 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.059 | 0.05 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.059 | 0.05 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.085 | 0.05 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.1 | 0.05 |